Delivery Order SPE2DB25D3202-SPE2DB25FTAZX
- Not listed
- The Defense Logistics Agency awarded a $27,961.22 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vaccine syringes. The contract, which is non-set-aside and competitively awarded, has a firm fixed price structure with an ultimate completion date of July 28, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $3,143.76 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vials (typhoid vaccine) on July 18, 2025, with completion targeted for July 21, 2025. This firm fixed price delivery order represents a pediatric vaccine procurement to support federal medical supply requirements. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $9,451.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for TYPHIM VI 25 MCG/0.5 ML vaccine syringes. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The vaccine will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $4,212.48 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes (typhoid vaccine). This firm fixed-price, non-set-aside contract is scheduled for completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,043.03 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vaccine vials on July 25, 2025, with completion expected by July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $6,899.00, with completion due by August 1, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $11,485.75 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,769.61 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vials (10 mL), a typhoid vaccine product. The award, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $27,596 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and is scheduled for completion by July 30, 2025. The vaccine product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $17,265.80 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial (10ML), a typhoid vaccine product. This firm fixed-price contract, awarded on July 30, 2025, represents a non-competitive set-aside delivery order with an ultimate completion date of July 31, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTAZXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vaccine vials with a ceiling value of $2,210.79. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract vehicle under AmerisourceBergen's broader pharmaceutical supply relationship with the Defense Logistics Agency. This award falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen is a major pharmaceutical distributor providing critical medical supplies including vaccines, medications, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The company's federal contract portfolio demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/25/25 |